The Journal of Organic Chemistry
Article
were averaged for each analysis. NMR spectra were processed using
MestReNova Version 14.0.0-23239 (Mestrelab Research S.L).
Whittaker smoother baseline correction was applied, and linear
correction was used for all integrals. Note that residual signals
between 5.5 and 6.5 ppm often derive from solvent suppression and
shift depending on sample pH.
117.6, 60.6, 59.7, 43.8, 22.6, 20.4; HRMS (ESI) m/z: [M − Br]+
Calcd for C15H23N2: 231.1856; Found 231.1856.
1,3-Diethyl-1H-benzo[d][1,2,3]triazol-3-ium iodide (20). Ac-
cording to the general procedure, benzotriazole (2.0 mmol, 1.0
equiv), ethyliodide (4.4 mmol, 2.2 equiv), K2CO3 (2.4 mmol, 1.2
equiv), and 10 mL MeCN were used to synthesize the title compound
20 as white solid (298 mg, 49% yield). 1H NMR (400 MHz,
CD3OD): δ 8.36−8.28 (m, 2H), 8.03−7.96 (m, 2H), 5.07 (q, J = 7.3
Hz, 4H), 1.79 (t, J = 7.3 Hz, 6H); 13C{1H} NMR (100 MHz,
CD3OD): δ 136.2, 132.3, 114.8, 48.6, 14.3; HRMS (ESI) m/z: [M −
I]+ Calcd for C10H14N3: 176.1182; Found 176.1183.
Chemicals. 3-(Trimethylsilyl)-1-propanesulfonic acid sodium salt
(NaDSS) (TCI Chemicals), methanol-d3 (Acros), methanol-d4
(Cambridge Isotope Laboratories), potassium hydroxide (Mallinck-
rodt), tetrabutylammonium bromide (7), and tetradecyltrimethylam-
monium bromide (8) (Sigma-Aldrich) were all used as received. The
model compounds were prepared according to literature procedures:
1-benzylquinuclidin-1-ium bromide (1);60 benzyltrimethylammonium
bromide (2);14 1-benzyl-1,4-diazabicyclo[2.2.2]octan-1-ium bromide
(3);61 4-benzyl-4-methylmorpholin-4-ium bromide (4);61 N-benzyl-
N-cyclohexyl-N-methylcyclohexanaminium bromide (5);11 1-hexyl-1-
methylpiperidin-1-ium bromide (6);62 1-ethyl-1-methylpyrrolidin-1-
ium bromide (9);63 6-azaspiro[5.5]undecan-6-ium bromide (10);9 5-
azaspiro[4.5]decan-5-ium bromide (13);42 1,3-di-n-butyl-2-(2,6-di-
methylphenyl)-4,5-diphenylimidazolium iodide (15);14 1-benzyl-2-
(2,6-dimethylphenyl)-3-methyl-4,5-diphenylimidazolium (16);14 1-
benzyl-2,3-dimethylimidazolium bromide (17);14 1-benzyl-3-methyl-
imidazolium bromide (18);14 1,3-dimethyl-2-mesityl-1H-benzimida-
zolium iodide (19);64 1-benzylpyridin-1-ium chloride (21);65 N-
[bis(dimethylamino)methylene]-N-methyl-1-phenylmethanaminium
iodide (22);66 tetrakis[cyclohexyl(methyl)amino]phosphonium hexa-
fluorophosphate (23),67 tetrakis(pyrrolidin-1-yl)phosphonium hexa-
fluorophosphate (24);10 benzyl-tris(2,4,6-trimethoxyphenyl)-
phosphonium bromide (25);68 and benzyltrimethylphosphonium
bromide (26).69
Model Compound Study Procedures. Stock solutions of basic
methanol were prepared by dissolving KOH (1 M or 2 M) and 3-
(trimethylsilyl)-1-propanesulfonic acid sodium salt (0.0250 M) in
CD3OH.15,29 For example, a 1 M solution was prepared by dissolving
KOH (142 mg, 2.51 mmol) and NaDSS (13.6 mg, 0.0625 mmol) in
2.50 mL of CD3OH. The model compound (0.05 M for 1 M KOH
and 0.03 M for 2 M KOH) was dissolved in the methanol solution
(0.50 mL) and passed through a glass wool plug into an NMR tube.
The NMR tube was flame-sealed and analyzed by 1H NMR
spectroscopy for the initial time point. Integration of a selected
signal in the model compound relative to a signal related to 3-
(trimethylsilyl)-1-propanesulfonic acid sodium salt provided the initial
quantity of model compound. The tube was heated in an oil bath at
80 °C. At specified time points, every 5 days, the tubes were removed,
cooled to room temperature, and analyzed by 1H NMR spectroscopy
to determine the quantity of model compound remaining (1H NMR
1
spectra are provided). The H NMR spectra of 15, 16, 23, and 24
under standard protocol conditions (1 M and 2 M KOH in CD3OH
at 80 °C for 30 days) were previously reported.10,14 The final cation
percentage remaining results were covered in our previous viewpoint.15
General Model Compound Synthesis Procedure. A modified
literature procedure was used.9 To a predried 50 mL Teflon-lined
seal-tube was added K2CO3 (2.4 mmol, 1.2 equiv). The flask was left
under vacuum for 10 min, and then refilled with N2. This process was
repeated three times, followed by the addition of the corresponding
nucleophile (2.0 mmol, 1.0 equiv), alkyl halide, and MeCN (10 mL).
The tube was then sealed under N2 and warmed up to 80 °C, and the
reaction was maintained under stirring at 80 °C for 16 h. After cooling
to 22 °C, the mixture was diluted with CH2Cl2 and filtered through
cotton. The filtrate was then concentrated and triturated in Et2O to
afford the model compounds as white solids.
3-Isopropyl-3,6-diazaspiro[5.5]undecan-6-ium bromide
(11). According to the general procedure, 1-isopropylpiperazine
(2.0 mmol, 1.0 equiv), 1,5-dibromopropane (2.0 mmol, 1.0 equiv),
K2CO3 (2.4 mmol, 1.2 equiv), and 10 mL MeCN were used to
synthesize the title compound 11 as white solid (466 mg, 84% yield).
1H NMR (400 MHz, CD3OD): δ 3.57−3.45 (m, 8H), 2.91−2.76 (m,
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge at
■
sı
Expanded data table, NMR and HRMS spectra, and
degradation product assignment (PDF).
AUTHOR INFORMATION
Corresponding Authors
■
Kevin J. T. Noonan − Department of Chemistry, Carnegie
Mellon University, Pittsburgh, Pennsylvania 15213-2617,
Geoffrey W. Coates − Department of Chemistry and
Chemical Biology, Baker Laboratory, Cornell University,
Ithaca, New York 14853-1301, United States; orcid.org/
5H), 1.96−1.84 (m, 4H), 1.79−1.66 (m, 2H), 1.10 (d, J = 6.5 Hz,
6H); 13C{1H} NMR (100 MHz, CD3OD): δ 60.8 (br), 60.3, 55.3,
43.0, 22.6, 20.4, 18.8; HRMS (ESI) m/z: [M − Br]+ Calcd for
C12H25N2: 197.2012; Found 197.2011.
3-Methyl-3,6-diazaspiro[5.5]undecan-6-ium bromide (12).
According to the general procedure, 1-methylpiperazine (2.0 mmol,
1.0 equiv), 1,5-dibromopropane (2.0 mmol, 1.0 equiv), K2CO3 (2.4
mmol, 1.2 equiv), and 10 mL MeCN were used to synthesize the title
Authors
Wei You − Department of Chemistry and Chemical Biology,
Baker Laboratory, Cornell University, Ithaca, New York
14853-1301, United States; Beijing National Laboratory for
Molecular Sciences (BNLMS), CAS Key Laboratory of
Engineering Plastics, Institute of Chemistry, Chinese Academy
Kristina M. Hugar − Department of Chemistry and Chemical
Biology, Baker Laboratory, Cornell University, Ithaca, New
1
compound 12 as white solid (256 mg, 51% yield). H NMR (400
MHz, CD3OD): δ 3.61−3.45 (m, 8H), 2.77 (t, J = 5.3 Hz, 4H), 2.40
(s, 3H), 1.91 (p, J = 6.0 Hz, 4H), 1.78−1.67 (m, 2H); 13C{1H} NMR
(100 MHz, CD3OD): δ 60.7 (br), 59.7, 48.6, 45.2, 22.6, 20.4; HRMS
(ESI) m/z: [M − Br]+ C10H21N2 169.1699; Found 169.1699.
3-Phenyl-3,6-diazaspiro[5.5]undecan-6-ium bromide (14).
According to the general procedure, 1-phenylpiperazine (2.0 mmol,
1.0 equiv), 1,5-dibromopropane (2.0 mmol, 1.0 equiv), K2CO3 (2.4
mmol, 1.2 equiv), and 10 mL MeCN were used to synthesize the title
1
compound 14 as white solid (280 mg, 45% yield). H NMR (400
MHz, CD3OD): δ 7.29 (t, J = 7.7 Hz, 2H), 7.04 (d, J = 8.1 Hz, 2H),
6.92 (t, J = 7.3 Hz, 1H), 3.70 (t, J = 5.2 Hz, 4H), 3.58 (t, J = 5.8 Hz,
4H), 3.51 (t, J = 5.2 Hz, 4H), 1.95 (p, J = 6.0 Hz, 4H), 1.76 (p, J = 6.1
Hz, 2H); 13C{1H} NMR (100 MHz, CD3OD): δ 150.9, 130.3, 122.1,
Ryan C. Selhorst − Department of Chemistry, Carnegie
Mellon University, Pittsburgh, Pennsylvania 15213-2617,
United States
G
J. Org. Chem. XXXX, XXX, XXX−XXX